ChiRhoStim Articles
Repligen narrows loss 87% in fiscal 4th-qtr
18 June 2007
Repligen's FY 2005 sees 35% sales rise
6 June 2005
Repligen's RG1068 fails in autism trial
5 January 2004
Pharmagene starts Ph II trial of PGN0052
22 December 2003
Showing 1-4 of 4 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
